Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH MEDIA
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC

Simple, Portable, Gas Flow Analyzer Provides Immediate Results

By BiotechDaily International staff writers
Posted on 13 Feb 2013
 Image: the VT305 gas flow analyzer (Photo courtesy of Fluke Biochemical).
Image: the VT305 gas flow analyzer (Photo courtesy of Fluke Biochemical).
A new gas flow analyzer is a small lightweight instrument, simple to use, and engineered for efficiency.

An intuitive four-button control panel, auto-orienting color LCD screen, and single flow channel are the reason for the simplicity of the VT305. Additionally, the VT305 provides instant readable graphs, which can be saved or transferred using an SD [secure digital] card. The automation provided by the Ansur Test Automation software helps reduce human error, improves data consistency, and ensures compliance with original equipment manufacturer (OEM) requirements. In addition, the VT305 tests ventilators and all other gas flow and pressure-producing devices including anesthesia machines, insufflators, suction devices, pressure gauges, flow meters, etc. The VT305 Gas Flow Analyzer is the efficient, versatile choice for biomeds looking to complete their test and measurement fleet.

Designed for the highly mobile biomed or service engineer, the VT305 Gas Flow Analyzer features internal sensors making connecting to medical devices a fast and easy process, explained Jerry Zion, product manager for Fluke Biomedical (Everett, WA, USA) the company that produces the instrument. He added, "No additional parts are required and the VT305 fits in your hand. You can get instant results in three simple steps. The VT305 will be the portable test tool of choice for highly mobile users."

Related Links:

Fluke Biomedical



WATERS CORPORATION

Channels

Genomics/Proteomics

view channel
Image: Electron micrograph of Hepatitis C virus purified from cell culture. Scale bar is 50 nanometers (Photo courtesy of the Center for the Study of Hepatitis C, the Rockefeller University).

Oxidized LDL Predicts Response to Interferon Treatment of Chronic Hepatitis C and May Be a Treatment Option

Oxidized low-density lipoprotein (oxLDL) in the blood was shown to predict responsiveness to interferon treatment in patients with chronic Hepatitis C virus (HCV) infection and to inhibit spread of the... Read more

Drug Discovery

view channel
Image: Molecular model of the anti-cancer drug 5-fluorouracil (Photo courtesy of Wikimedia Commons).

Novel Microcapsule Approach Reduces Toxic Side Effects of Chemotherapy

Cancer researchers have reduced chemotherapy's toxic side effects by using nanoporous capsules to transport an enzyme to the site of a tumor where it is activated by a selective heating process to convert... Read more

Business

view channel

NanoString and MD Anderson Collaborate on Development of Novel Multi-Omic Expression Profiling Assays for Cancer

The University of Texas MD Anderson Cancer Center (Houston, TX, USA) and NanoString Technologies, Inc. (Seattle, WA, USA) will partner on development of a revolutionary new type of assay—simultaneously profiling gene and protein expression, initially aiming to discover and validate biomarker signatures for immuno-oncology... Read more
 

Events

02 Jun 2015 - 03 Jun 2015
15 Jun 2015 - 18 Jun 2015
Copyright © 2000-2015 Globetech Media. All rights reserved.